TY  - JOUR

T1  - Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures

JO  - Neurology

PY  - 1997/01/01

AU  - Beydoun A

AU  - Fischer J

AU  - Labar DR

AU  - Harden C

AU  - Cantrell D

AU  - Uthman BM

AU  - Sackellares JC

AU  - Abou-Khalil B

AU  - Ramsay RE

AU  - Hayes A

AU  - Greiner M et al

ED  - 

DO  - DOI: 10.1212/wnl.49.3.746

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 49

IS  - 3

SP  - 746

EP  - 752

Y2  - 2024/12/22

ER  -